Insulin as an autoantigen in NOD/human diabetes
- 29 February 2008
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Immunology
- Vol. 20 (1), 111-118
- https://doi.org/10.1016/j.coi.2007.11.005
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Priming and effector dependence on insulin B:9–23 peptide in NOD islet autoimmunityJCI Insight, 2007
- Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRPJCI Insight, 2006
- An immunologic homunculus for type 1 diabetesJCI Insight, 2006
- Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing TregsJCI Insight, 2006
- TGF- signaling is required for the function of insulin-reactive T regulatory cellsJCI Insight, 2006
- Self-antigen–presenting cells expressing diabetes-associated autoantigens exist in both thymus and peripheral lymphoid organsJCI Insight, 2001
- A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulinJCI Insight, 2001
- Update on Major Trials for the Prevention of Type I Diabetes Mellitus: The American Diabetes Prevention Trial (DPT-1) and the European Nicotinamide Diabetes Intervention Trial (ENDIT)Journal of Pediatric Endocrinology and Metabolism, 2001
- Insulin desensitization with insulin lispro and an insulin pump in a 5-year-old childAnnals of Allergy, Asthma & Immunology, 2000
- Dual Overlapping Peptides Recognized by Insulin Peptide B:9–23 T Cell Receptor AV13S3 T Cell Clones of the NOD MouseJournal of Autoimmunity, 2000